Status:
TERMINATED
Magnetic Resonance Imaging (MRI) Correlation to Standard of Care Imaging and Pathology Correlation in Breast Carcinoma
Lead Sponsor:
AHS Cancer Control Alberta
Collaborating Sponsors:
Cross Cancer Institute
Conditions:
Breast Neoplasms
Eligibility:
FEMALE
18+ years
Phase:
PHASE2
Brief Summary
Magnetic Resonance Imaging (MRI) is a well known imaging tool for the investigation and diagnosis of breast cancer, used in addition to breast mammograms and ultrasound. Recent publications suggest th...
Detailed Description
Background Information In addition to the gold standard imaging of mammography and breast ultrasound, magnetic resonance imaging (MRI) has become a well established investigational modality for the d...
Eligibility Criteria
Inclusion
- females 18 years or older
- females referred to Dr. Kelly Dabbs for breast cancer surgery with pathology positive for breast carcinoma, any subtype
Exclusion
- pacemakers
- aneurysm clips
- cochlear implants
- epicardial pacemaker wires
- neural stimulators, etc.
- significant claustrophobia
- significant obesity that would not enable the patient to fit in the scanner
- pregnancy or breast feeding
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2010
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00291304
Start Date
March 1 2006
End Date
January 1 2010
Last Update
June 14 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cross Cancer Institute
Edmonton, Alberta, Canada, T6G 1Z2